Home Cart 0 Sign in  
X

[ CAS No. 102-52-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 102-52-3
Chemical Structure| 102-52-3
Chemical Structure| 102-52-3
Structure of 102-52-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 102-52-3 ]

Related Doc. of [ 102-52-3 ]

Alternatived Products of [ 102-52-3 ]

Product Details of [ 102-52-3 ]

CAS No. :102-52-3 MDL No. :MFCD00008488
Formula : C7H16O4 Boiling Point : -
Linear Structure Formula :- InChI Key :XHTYQFMRBQUCPX-UHFFFAOYSA-N
M.W : 164.20 Pubchem ID :66019
Synonyms :

Calculated chemistry of [ 102-52-3 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 6
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 40.1
TPSA : 36.92 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.07 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.43
Log Po/w (XLOGP3) : 0.32
Log Po/w (WLOGP) : 0.61
Log Po/w (MLOGP) : 0.04
Log Po/w (SILICOS-IT) : 0.42
Consensus Log Po/w : 0.77

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.66
Solubility : 35.6 mg/ml ; 0.217 mol/l
Class : Very soluble
Log S (Ali) : -0.66
Solubility : 36.0 mg/ml ; 0.219 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.88
Solubility : 21.4 mg/ml ; 0.131 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.95

Safety of [ 102-52-3 ]

Signal Word:Danger Class:3
Precautionary Statements:P210-P403+P235 UN#:1993
Hazard Statements:H225 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 102-52-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 102-52-3 ]
  • Downstream synthetic route of [ 102-52-3 ]

[ 102-52-3 ] Synthesis Path-Upstream   1~51

  • 1
  • [ 102-52-3 ]
  • [ 598-52-7 ]
  • [ 1450-85-7 ]
YieldReaction ConditionsOperation in experiment
23% With potassium carbonate In ethanol; water EXAMPLE 4
2(1 H)-Pyrimidinethione, 1-methyl
To a stirred mixture of 1-methyl-2-thiourea (76.6 g, 0.85 mol) and malonaldehyde bis(dimethyl acetal) (126.8 g, 0.77 mol) in EtOH (1.5 L) was added 10 M HCI (76.6 mL, 0.77 mol) in one portion.
The resulting mixture was stirred at 25° C. for 18 h, then spin-evaporated in vacuo.
The residue was dissolved in H2O (1.25 L).
The solution was made alkaline by the portionwise addition of K2CO3 and extracted with CH2Cl2 (4*500 mL).
The combined extracts were dried over MgSO4 and spin-evaporated in vacuo to a solid.
The crude product was recrystallized from EtOH (600 mL) then dried to constant weight in vacuo at room temperature to give 22.9 g (23percent) of product; mp 186-188° C. (uncorrected).
An additional reaction was performed to give a total of 40.7 g.
23% With potassium carbonate In ethanol; water EXAMPLE 4
2(1H)-Pyrimidinethione, 1-methyl
To a stirred mixture of 1-methyl-2-thiourea (76.6 g, 0.85 mol) and malonaldehyde bis(dimethyl acetal) (126.8 g, 0.77 mol) in EtOH (1.5 L) was added 10 M HCI (76.6 mL, 0.77 mol) in one portion.
The resulting mixture was stirred at 25° C. for 18 h, then spin-evaporated in vacuo.
The residue was dissolved in H2O (1.25 L).
The solution was made alkaline by the portionwise addition of K2CO3 and extracted with CH2Cl2 (4*500 mL).
The combined extracts were dried over MgSO4 and spin-evaporated in vacuo to a solid.
The crude product was recrystallized from EtOH (600 mL) then dried to constant weight in vacuo at room temperature to give 22.9 g (23percent) of product; mp 186-188° C. (uncorrected).
An additional reaction was performed to give a total of 40.7 g.
Reference: [1] Patent: US2002/12639, 2002, A1,
[2] Patent: US6495125, 2002, B2,
  • 2
  • [ 609-40-5 ]
  • [ 102-52-3 ]
  • [ 272-23-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2014, vol. 57, # 18, p. 7577 - 7589
  • 3
  • [ 102-52-3 ]
  • [ 100-52-7 ]
  • [ 7431-45-0 ]
Reference: [1] Tetrahedron Letters, 1981, vol. 22, # 15, p. 1453 - 1454
  • 4
  • [ 102-52-3 ]
  • [ 1670-14-0 ]
  • [ 7431-45-0 ]
Reference: [1] Synthetic Communications, 1997, vol. 27, # 14, p. 2521 - 2526
  • 5
  • [ 102-52-3 ]
  • [ 107-91-5 ]
  • [ 20577-27-9 ]
Reference: [1] Patent: US6335345, 2002, B1, . Location in patent: Page column 59
  • 6
  • [ 102-52-3 ]
  • [ 619-27-2 ]
  • [ 25688-18-0 ]
Reference: [1] Tetrahedron, 2001, vol. 57, # 20, p. 4397 - 4403
[2] Magnetic Resonance in Chemistry, 2011, vol. 49, # 8, p. 537 - 542
  • 7
  • [ 4930-98-7 ]
  • [ 102-52-3 ]
  • [ 25700-11-2 ]
YieldReaction ConditionsOperation in experiment
70% With hydrogenchloride In ethanol; water EXAMPLE 176
(7R)-7-[(phenylacetyl)amino]-3-(1-(pyrid-2-yl)pyrazol-5-ylthio)-3-cephem-4-carboxylate, 4-methoxybenzyl ester
To a stirring solution of 2-pyridylhydrazine (3.30 g, 30.2 mmol) and malonaldehyde bis (dimethylacetal) (4.96 g, 30.2 mmol) in absolute ethanol (60 mL) at room temperature was added concentrated HCl until the mixture was acidic (3 mL).
The mixture was heated at reflux for 3 h, and was allowed to cool to room temperature.
The mixture was concentrated with a rotary evaporator, and the residue was triturated with ether and filtered.
The remaining solid was dissolved in water, basified with saturated aqueous sodium bicarbonate, and extracted with ethyl acetate.
The organic extracts were washed with water and brine, dried (sodium sulfate), and concentrated with a rotary evaporator to afford 3.10 g (70percent) of 1-(pyrid-2-yl)pyrazole. 1 H NMR (CDCl3) δ6.48 (dd, 1, J=1, 2), 7.20 (dd, 1, J=8, 10), 7.75 (d, 1, J=l), 7.82 (dt, 1, J=2, 10), 8.00 (d, 1, J=10), 8.42 (dd, 1, J=2, 8), 8.59 (d, 1, J=2).
70% With hydrogenchloride In ethanol; water EXAMPLE 176
(7R)-7-[(phenylacetyl)amino]-3-(1-(pyrid-2-yl)pyrazol-5-ylthio)-3-cephem-4-carboxylate, 4-methoxybenzyl ester
To a stirring solution of 2-pyridylhydrazine (3.30 g, 30.2 mmol) and malonaldehyde bis(dimethylacetal) (4.96 g, 30.2 mmol) in absolute ethanol (60 mL) at room temperature was added concentrated HCl until the mixture was acidic (3 mL).
The mixture was heated at reflux for 3 h, and was allowed to cool to room temperature.
The mixture was concentrated with a rotary evaporator, and the residue was triturated with ether and filtered.
The remaining solid was dissolved in water, basified with saturated aqueous sodium bicarbonate, and extracted with ethyl acetate.
The organic extracts were washed with water and brine, dried (sodium sulfate), and concentrated with a rotary evaporator to afford 3.10 g (70percent) of 1-(pyrid-2-yl)pyrazole. 1 H NMR (CDCl3) δ6.48 (dd, 1, J=1, 2), 7.20 (dd, 1, J=8, 10), 7.75 (d, 1, J=1), 7.82 (dt, 1, J=2, 10), 8.00 (d, 1, J=10), 8.42 (dd, 1, J=2, 8), 8.59 (d, 1, J=2).
70% With hydrogenchloride In ethanol; water Example 176
(7R)-7-[(phenylacetyl)amino]-3-(1-(pyrid-2-yl)pyrazol-5-ylthio)-3-cephem-4-carboxylate, 4-methoxybenzyl ester
To a stirring solution of 2-pyridylhydrazine (3.30 g, 30.2 mmol) and malonaldehyde bis(dimethylacetal) (4.96 g, 30.2 mmol) in absolute ethanol (60 mL) at room temperature was added concentrated HCl until the mixture was acidic (3 mL).
The mixture was heated at reflux for 3 h, and was allowed to cool to room temperature.
The mixture was concentrated with a rotary evaporator, and the residue was triturated with ether and filtered.
The remaining solid was dissolved in water, basified with saturated aqueous sodium bicarbonate, and extracted with ethyl acetate.
The organic extracts were washed with water and brine, dried (sodium sulfate), and concentrated with a rotary evaporator to afford 3.10 g (70percent) of 1-(pyrid-2-yl)pyrazole. 1 H NMR (CDCl3) δ6.48 (dd, 1, J=1, 2), 7.20 (dd, 1, J=8, 10), 7.75 (d, 1, J=1), 7.82 (dt, 1, J=2, 10), 8.00 (d, 1, J=10), 8.42 (dd, 1, J=2, 8), 8.59 (d, 1, J=2).
70% With hydrogenchloride In ethanol; water EXAMPLE 176
(7R)-7-[(phenylacetyl)amino]-3-(1-(pyrid-2-yl)pyrazol-5-ylthio)-3-cephem-4-carboxylate, 4-methoxybenzyl ester
To a stirring solution of 2-pyridylhydrazine (3.30 g, 30.2 mmol) and malonaldehyde bis(dimethylacetal) (4.96 g, 30.2 mmol) in absolute ethanol (60 mL) at room temperature was added concentrated HCl until the mixture was acidic (3 mL).
The mixture was heated at reflux for 3h, and was allowed to cool to room temperature.
The mixture was concentrated with a rotary evaporator, and the residue was triturated with ether and filtered.
The remaining solid was dissolved in water, basified with saturated aqueous sodium bicarbonate, and extracted with ethyl acetate.
The organic extracts were washed with water and brine, dried (sodium sulfate), and concentrated with a rotary evaporator to afford 3.10 g (70percent) of 1-(pyrid-2-yl)pyrazole. 1 H NMR (CDCl3) δ6.48 (dd, 1, J=1, 2), 7.20 (dd, 1, J=8, 10), 7.75 (d, 1, J=l), 7.82 (dt, 1, J=2, 10), 8.00 (d, 1, J=10), 8.42 (dd, 1, J=2, 8), 8.59 (d, 1, J=2).
70% With hydrogenchloride In ethanol; water Example 176
(7R)-7-[(phenylacetyl)amino]-3-(1-(pyrid-2-yl)pyrazol-5-ylthio)-3-cephem-4-carboxylate, 4-methoxybenzyl ester
To a stirring solution of 2-pyridylhydrazine (3.30 g, 30.2 mmol) and malonaldehyde bis(dimethylacetal) (4.96 g, 30.2 mmol) in absolute ethanol (60 mL) at room temperature was added concentrated HCl until the mixture was acidic (3 mL).
The mixture was heated at reflux for 3 h, and was allowed to cool to room temperature.
The mixture was concentrated with a rotary evaporator, and the residue was triturated with ether and filtered.
The remaining solid was dissolved in water, basified with saturated aqueous sodium bicarbonate, and extracted with ethyl acetate.
The organic extracts were washed with water and brine, dried (sodium sulfate), and concentrated with a rotary evaporator to afford 3.10 g (70percent) of 1-(pyrid-2-yl)pyrazole. 1 H NMR (CDCl3) δ 6.48 (dd, 1, J=1, 2), 7.20 (dd, 1, J=8, 10), 7.75 (d, 1, J=1), 7.82 (dt, 1, J=2, 10), 8.00 (d, 1, J=10), 8.42 (dd, 1, J=2, 8), 8.59 (d, 1, J=2).

Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 19, p. 4645 - 4648
[2] Patent: US5604218, 1997, A,
[3] Patent: US5698547, 1997, A,
[4] Patent: US5607926, 1997, A,
[5] Patent: US5756493, 1998, A,
[6] Patent: US5593986, 1997, A,
[7] Patent: US5789584, 1998, A,
  • 8
  • [ 102-52-3 ]
  • [ 102908-37-2 ]
YieldReaction ConditionsOperation in experiment
179.4mg for 2 h; Reflux a)
1-(2-Methoxyphenyl)-1H-pyrazol
200 mg of 2-methoxyphenyl hydrazine hydrochloride was dissolved in 5 ml of ethanol, and 189 μl of malonaldehyde bisdimethylacetal was added and heated at reflux for 2 hours.
To the reaction mixture was added 50 ml of water, neutralized with a saturated aqueous solution of sodium carbonate, and extracted with 60 ml of ethyl acetate.
After the organic layer was dried over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure to yield 179.4 mg of the title compound.
1H-NMR (CDCl3); δ (ppm) 3.87 (3H, s), 6.42 (1H, d, J=2.4 Hz), 7.02-7.07 (2H, m), 7.27-7.32 (1H, m), 7.68-7.72 (2H, m), 8.01 (1H, d, J=2.4 Hz).
MS (FAB); m/z 175 (M+H)+
179.4 mg for 2 h; Reflux 200 mg of 2-methoxyphenylhydrazine hydrochloride was dissolved in 5 ml of ethanol and 189 μl of malonaldehyde bisdimethylacetal was added, followed by heating to reflux for 2 hours. To the reaction mixture was added 50 ml of water, followed by neutralizing with a saturated aqueous sodium carbonate solution and extracting with 60 ml of ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate and subsequently the solvent was distilled off under reduced pressure to afford 179.4 mg of the title compound. 1H-NMR (CDCl3); δ (ppm) 3.87 (3H, s), 6.42 (1H, d, J=2.4 Hz), 7.02-7.07 (2H, m), 7.27-7.32 (1H, m), 7.68-7.72 (2H, m), 8.01 (1H, d, J=2.4 Hz). MS (FAB); m/z 175 (M+H)+
179.4 mg for 2 h; Reflux a) 1-(2-Methoxyphenyl)-1H-pyrazole [0154] 200 mg of 2-methoxyphenylhydrazine hydrochloride was dissolved in 5 ml of ethanol and 189 µl of malonaldehyde bisdimethylacetal was added, followed by heating to reflux for 2 hours. To the reaction mixture was added 50 ml of water, followed by neutralizing with a saturated aqueous sodium carbonate solution and extracting with 60 ml of ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate and subsequently the solvent was distilled off under reduced pressure to afford 179.4 mg of the title compound. 1H-NMR(CDCl3); δ (ppm) 3.87 (3H,s), 6.42 (1H, d, J=2.4Hz), 7.02-7.07 (2H, m), 7.27-7.32 (1H, m), 7.68-7.72 (2H, m), 8.01 (1H, d, J=2.4Hz). MS (FAB); m/z 175 (M+H)+
Reference: [1] Patent: US2013/317074, 2013, A1, . Location in patent: Paragraph 0333; 0334; 0335
[2] Patent: US2014/30209, 2014, A1, . Location in patent: Paragraph 0146; 0147; 0148
[3] Patent: EP2881114, 2015, A1, . Location in patent: Paragraph 0154
  • 9
  • [ 102-52-3 ]
  • [ 6971-45-5 ]
  • [ 102908-37-2 ]
YieldReaction ConditionsOperation in experiment
179.4 mg for 2 h; Reflux 200 mg of 2-methoxyphenylhydrazine hydrochloride was dissolved in 5 ml of ethanol and 189 μl of malonaldehyde bisdimethylacetal was added, followed by heating to reflux for 2 hours. To the reaction mixture was added 50 ml of water, followed by neutralizing with a saturated aqueous sodium carbonate solution and extracting with 60 ml of ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate and subsequently the solvent was distilled off under reduced pressure to afford 179.4 mg of the title compound. 1H-NMR (CDCl3); δ (ppm) 3.87 (3H,s), 6.42 (1H, d, J=2.4Hz), 7.02-7.07 (2H, m), 7.27-7.32 (1H, m), 7.68-7.72 (2H, m), 8.01 (1H, d, J=2.4Hz). MS (FAB); m/z 175 (M+H)+
179.4 mg for 2 h; Reflux [0176] 200 mg of 2-methoxyphenylhydrazine hydrochloride was dissolved in 5 ml of ethanol and 189 μl of malonaldehyde bisdimethylacetal was added, followed by heating to reflux for 2 hours. To the reaction mixture was added 50 ml of water, followed by neutralizing with a saturated aqueous sodium carbonate solution and extracting with 60 ml of ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate and subsequently the solvent was distilled off under reduced pressure to afford 179.4 mg of the title compound. [0177] 1H-NMR (CDCl3); δ (ppm) 3.87 (3H, s), 6.42 (1H, d, J=2.4 Hz), 7.02-7.07 (2H, m), 7.27-7.32 (1H, m), 7.68-7.72 (2H, m), 8.01 (1H, d, J=2.4 Hz). [0178] MS (FAB); m/z 175 (M+H)+
Reference: [1] Patent: EP2889031, 2015, A1, . Location in patent: Paragraph 0128
[2] Patent: US2015/209301, 2015, A1, . Location in patent: Paragraph 0176-0178
  • 10
  • [ 102-52-3 ]
  • [ 7400-27-3 ]
  • [ 15754-60-6 ]
YieldReaction ConditionsOperation in experiment
89% With hydrogenchloride In ethanolHeating / reflux A mixture of 1 , 1 ,3,3-tetramethoxypropane (37 g, 226 mmol), tert-butyl-hydrazine hydrochloride (28 g, 226 mmol) and cone HCl (60 mL, 720 mmol) in EtOH (300 mL) was heated at reflux overnight. The mixture was poured into water and the resulting mixture was extracted with ether. The combined organics were washed with brine, dried (MgSO4) and concentrated in vacuo to give 1-tert-butyl-lH-pyrazole (25 g, 89percent yield). 1H NMR (400 MHz, OMSO-Cl6): δl.n (s, 1 H), 7.38 (s, 1 H), 6.17 (s, 1 H), 1.47 (s, 9 H); MS (ESI) m/z: 125.1 [M+H]+.
89% With hydrogenchloride In ethanol; waterReflux A mixture of 1,1,3,3-tetramethoxypropane (3.7 g, 22.6 mmol), tert-butylhydrazinehydrochloride (2.8 g, 22.6 mmol), and conc. HCl (6 mL, 72 mmol) in EtOH (30 mL) was heated at reflux overnight. The reaction mixture was poured into water and the resulting mixture wasextracted with ether (30 mL x 3). The combined organics was washed with brine (20 mL), dried over MgSO4, and concentrated under reduced pressure to afford 1-tert-butyl-1H-pyrazole as awhite solid (2.5 g, 89percent). MS (ESI) m/z: 125 [M+H].
72%
Stage #1: With hydrogenchloride In ethanol; water at 50℃; for 2 h; Reflux; Industry scale
Stage #2: With sodium hydroxide In water
To a mixture of 1 ,1 ,3,3-tetramethoxypropane (3.82kg, 23.27mol) and tert- butylhydrazine hydrochloride (2.9kg, 23.27mol) in ethanol (24.54kg), cone HCI (4.72kg ,46.55mol) was added, keeping the temperature below 50°C. The reaction mixture was then rapidly heated to reflux. After ca. 2h the reaction was sampled and analysed by NMR. Pass criteria was <3.0percent starting material remaining. On receipt of a pass result the solution is cooled, diluted with water (8.29kg) and evaporated in vacuo (T<50°C, p<-0.08MPa) until approximately all of the original ethanol was removed. The solution was basified with 10M NaOH(aq), extracted with EtOAc (1 1 .1 1 kgx2) and the organic phase washed with saturated ammonium chloride solution (4.3ml/g x 2) and brine (4.3ml/g), then evaporated to give the title compound (2.08kg, 72percentyield) as a brown liquid (GC purity 99.70percenta/a).
72% With hydrogenchloride In ethanol; water at 50℃; for 0.2 h; Reflux; Industrial scale Stage a)
Preparation of 1-(1,1-Dimethylethyl)-1H-pyrazole (Intermediate 9)
To a mixture of 1,1,3,3-tetramethoxypropane (3.82 kg, 23.27 mol) and tert-butylhydrazine hydrochloride (2.9 kg, 23.27 mol) in ethanol (24.54 kg), conc HCl (4.72 kg, 46.55 mol) was added, keeping the temperature below 50° C.
The reaction mixture was then rapidly heated to reflux.
After ca.
2 h the reaction was sampled and analysed by NMR.
Pass criteria was <3.0percent starting material remaining.
On receipt of a pass result the solution is cooled, diluted with water (8.29 kg) and evaporated in vacuo (T<50° C., p<-0.08 MPa) until approximately all of the original ethanol was removed.
The solution was basified with 10M NaOH(aq), extracted with EtOAc (11.11 kg*2) and the organic phase washed with saturated ammonium chloride solution (4.3 ml/g*2) and brine (4.3 ml/g), then evaporated to give the title compound (2.08 kg, 72percent yield) as a brown liquid (GC purity 99.70percent a/a).
21.9 g With hydrogenchloride In ethanol for 2 h; Reflux To a stirred mixture of 34.48 g of 1,1,3,3-tetramethoxy-propane and 26.20 g tert.butyihydrazine hydrochloride in 230 mL ethanol was added 40.0 mL conc. hydrochloric acid dropwise below 50 00, then the mixture was stirred under reflux for 2 h. The reaction mixture was diluted with water. The solvent was almost removed by destillation and the aqueous residue extracted with diethylether. The combined aqueous phases were basified with iON sodium hydroxide solution and extracted with diethylether. The combined organic phases were washed with saturated brine, dried over sodium sulfate, filtered and concentrated in vacuo to yield 21.90 g of 1-tert-butyl-pyrazole as oil.Analysis: HPLC-MS: R1 = 0.412 mm (method A), M+H = 125

Reference: [1] Patent: WO2008/33999, 2008, A2, . Location in patent: Page/Page column 83
[2] Patent: WO2014/1377, 2014, A1, . Location in patent: Page/Page column 104
[3] Patent: WO2011/134971, 2011, A1, . Location in patent: Page/Page column 15; 16
[4] Patent: US2013/40984, 2013, A1, . Location in patent: Paragraph 0478-0479
[5] Patent: WO2017/42100, 2017, A1, . Location in patent: Page/Page column 42; 43
  • 11
  • [ 16461-94-2 ]
  • [ 102-52-3 ]
  • [ 55405-67-9 ]
YieldReaction ConditionsOperation in experiment
39% for 4 h; Reflux A. A solution of 3-amino-4-bromopyrazole (2.0 g, 12 mmol) and 1 ,1 ,3,3- tetramethoxypropane (4.1 mL, 25 mmol) in acetic acid (5 mL) was heated at reflux for 4 h. Water (2 mL) was added and the mixture heated at reflux for a further 0.5 h, allowed to cool to ambient temperature and concentrated in vacuo. The residue was triturated in methanol. The solid thus obtained was washed with cold methanol, ethyl acetate, and hexanes to provide 3-bromopyrazolo[1 ,5-a]pyrimidine as a brownish solid in 39percent yield (0.953 g): 1H NMR (300 MHz, DMSO-d6) £9.13 (d, J = 6.5 Hz, 1 H), 8.61 (s, 1 H), 8.35 (s, 1 H), 7.19-7.02 (m, 1 H); MS (ES+) m/z 197.9 (M + 1), 199.9 (M + 1).
Reference: [1] Patent: WO2013/64984, 2013, A1, . Location in patent: Page/Page column 66
[2] Patent: WO2009/85913, 2009, A1, . Location in patent: Page/Page column 68; 69
  • 12
  • [ 141-86-6 ]
  • [ 102-52-3 ]
  • [ 15992-83-3 ]
YieldReaction ConditionsOperation in experiment
72% at 70 - 75℃; for 0.666667 h; In the reaction flask with a stirrer was added 107 g of 2,6-diamino pyridine and 1070 ml phosphoric acid at room temperature was slowly added dropwise 241 g 1,1,3,3-tetramethoxypropane to the resulting solution, dropwise after an oil bath to heat up, control the internal temperature 70-75 ° C, for 40 minutes. Then the reaction mixture was poured into 5 liters of ice 5M aqueous sodium hydroxide solution, to ensure that pH> 10, the filter cake (200 ml × 2), and the filtrate was washed with methylene chloride and extracted with dichloromethane (300 ml × 2) the combined dichloromethane phases were washed with 100 g of anhydrous sodium sulfate, filtered, and concentrated to dryness, the resultant crude product was purified by column chromatography (packing agent is alumina, eluting with methylene chloride: methanol (v / v ) = 100: 1), to obtain 102 g of a red solid 1,8-naphthyridin-2-amine, yield 72percent, HPLC purity 96percent.
Reference: [1] Patent: CN105399739, 2016, A, . Location in patent: Paragraph 0019; 0020
[2] Angewandte Chemie - International Edition, 2017, vol. 56, # 12, p. 3349 - 3353[3] Angew. Chem., 2017, vol. 129, p. 3397 - 3401,5
[4] Journal of Heterocyclic Chemistry, 1997, vol. 34, # 3, p. 765 - 771
  • 13
  • [ 141-86-6 ]
  • [ 102-52-3 ]
  • [ 15936-09-1 ]
  • [ 15992-83-3 ]
Reference: [1] New Journal of Chemistry, 2017, vol. 41, # 3, p. 1073 - 1081
  • 14
  • [ 102-52-3 ]
  • [ 10300-69-3 ]
  • [ 54198-88-8 ]
Reference: [1] Patent: EP1422228, 2004, A1, . Location in patent: Page 207
[2] Patent: WO2015/90599, 2015, A1, . Location in patent: Page/Page column 45
  • 15
  • [ 102-52-3 ]
  • [ 20846-52-0 ]
  • [ 54198-88-8 ]
Reference: [1] Organic Letters, 2011, vol. 13, # 6, p. 1436 - 1439
[2] Bioorganic and Medicinal Chemistry, 2005, vol. 13, # 2, p. 363 - 386
  • 16
  • [ 109-53-5 ]
  • [ 149-73-5 ]
  • [ 102-52-3 ]
Reference: [1] Patent: EP1607381, 2005, A1, . Location in patent: Page/Page column 6
  • 17
  • [ 926-65-8 ]
  • [ 149-73-5 ]
  • [ 603151-66-2 ]
  • [ 102-52-3 ]
Reference: [1] Patent: EP1607381, 2005, A1, . Location in patent: Page/Page column 5-6
  • 18
  • [ 111-34-2 ]
  • [ 149-73-5 ]
  • [ 768388-22-3 ]
  • [ 102-52-3 ]
Reference: [1] Patent: EP1607381, 2005, A1, . Location in patent: Page/Page column 6
  • 19
  • [ 764-47-6 ]
  • [ 149-73-5 ]
  • [ 603151-65-1 ]
  • [ 102-52-3 ]
Reference: [1] Patent: EP1607381, 2005, A1, . Location in patent: Page/Page column 5
  • 20
  • [ 107-25-5 ]
  • [ 149-73-5 ]
  • [ 102-52-3 ]
Reference: [1] Patent: DE821201, 1949, ,
[2] DRP/DRBP Org.Chem.,
[3] Zhurnal Obshchei Khimii, 1957, vol. 27, p. 57,58,61;engl.Ausg.S.65,67,68
[4] Patent: US6395914, 2002, B1, . Location in patent: Page column 4
[5] Patent: US6395914, 2002, B1, . Location in patent: Page column 5
[6] DRP/DRBP Org.Chem.,
[7] Patent: US2527533, 1946, ,
  • 21
  • [ 108-05-4 ]
  • [ 149-73-5 ]
  • [ 102-52-3 ]
  • [ 98561-07-0 ]
Reference: [1] Patent: US6355844, 2002, B1, . Location in patent: Example 8
[2] Patent: US6395914, 2002, B1, . Location in patent: Page column 5-6
  • 22
  • [ 107-25-5 ]
  • [ 149-73-5 ]
  • [ 102-52-3 ]
  • [ 55546-58-2 ]
Reference: [1] Journal of Organic Chemistry, 1988, vol. 53, # 13, p. 2920 - 2925
  • 23
  • [ 67-56-1 ]
  • [ 107-02-8 ]
  • [ 102-52-3 ]
  • [ 14315-97-0 ]
  • [ 2806-84-0 ]
Reference: [1] Tetrahedron, 2006, vol. 62, # 42, p. 9846 - 9854
  • 24
  • [ 67-56-1 ]
  • [ 107-02-8 ]
  • [ 102-52-3 ]
  • [ 14315-97-0 ]
  • [ 2806-84-0 ]
  • [ 19060-10-7 ]
Reference: [1] Tetrahedron, 2006, vol. 62, # 42, p. 9846 - 9854
  • 25
  • [ 67-56-1 ]
  • [ 4190-06-1 ]
  • [ 102-52-3 ]
Reference: [1] Journal of Organic Chemistry, 2004, vol. 69, # 12, p. 4135 - 4139
  • 26
  • [ 926-65-8 ]
  • [ 149-73-5 ]
  • [ 102-52-3 ]
Reference: [1] Patent: EP1607381, 2005, A1, . Location in patent: Page/Page column 5
[2] Patent: EP1607381, 2005, A1, . Location in patent: Page/Page column 5
[3] Patent: EP1607381, 2005, A1, . Location in patent: Page/Page column 5
  • 27
  • [ 108-05-4 ]
  • [ 149-73-5 ]
  • [ 102-52-3 ]
  • [ 98561-07-0 ]
  • [ 15874-25-6 ]
Reference: [1] Patent: US6355844, 2002, B1, . Location in patent: Example 1
[2] Patent: US6355844, 2002, B1, . Location in patent: Example 9
[3] Patent: US6355844, 2002, B1, . Location in patent: Example 5
[4] Patent: US6355844, 2002, B1, . Location in patent: Example 2
  • 28
  • [ 108-05-4 ]
  • [ 149-73-5 ]
  • [ 102-52-3 ]
Reference: [1] Chemistry of Heterocyclic Compounds (New York, NY, United States), 1987, vol. 23, # 3, p. 316 - 320[2] Khimiya Geterotsiklicheskikh Soedinenii, 1987, vol. 23, # 3, p. 376 - 381
[3] Patent: US2459076, 1948, ,
[4] Patent: US2459076, 1948, ,
  • 29
  • [ 67-56-1 ]
  • [ 98561-07-0 ]
  • [ 102-52-3 ]
Reference: [1] Patent: US2823226, 1954, ,
[2] Patent: US2823226, 1954, ,
  • 30
  • [ 67-56-1 ]
  • [ 1165952-92-0 ]
  • [ 7424-91-1 ]
  • [ 102-52-3 ]
  • [ 108-59-8 ]
Reference: [1] Liebigs Annalen der Chemie, 1990, # 2, p. 185 - 188
[2] Liebigs Annalen der Chemie, 1990, # 2, p. 185 - 188
[3] Liebigs Annalen der Chemie, 1990, # 2, p. 185 - 188
  • 31
  • [ 67-56-1 ]
  • [ 542-92-7 ]
  • [ 102-52-3 ]
  • [ 63857-17-0 ]
  • [ 78923-06-5 ]
  • [ 19060-10-7 ]
Reference: [1] Journal of Organic Chemistry, 1990, vol. 55, # 24, p. 6024 - 6027
[2] Journal of Organic Chemistry, 1990, vol. 55, # 24, p. 6024 - 6027
  • 32
  • [ 67-56-1 ]
  • [ 19060-10-7 ]
  • [ 102-52-3 ]
Reference: [1] , 1970, vol. 6, p. 421 - 426[2] Zhurnal Organicheskoi Khimii, 1970, vol. 6, p. 422 - 428
  • 33
  • [ 60-33-3 ]
  • [ 102-52-3 ]
  • [ 107-02-8 ]
Reference: [1] Human and Experimental Toxicology, 1999, vol. 18, # 11, p. 677 - 682
  • 34
  • [ 506-32-1 ]
  • [ 102-52-3 ]
  • [ 107-02-8 ]
Reference: [1] Human and Experimental Toxicology, 1999, vol. 18, # 11, p. 677 - 682
  • 35
  • [ 67-56-1 ]
  • [ 624-67-9 ]
  • [ 102-52-3 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1973, vol. 7, # 9, p. 545 - 549[2] Khimiko-Farmatsevticheskii Zhurnal, 1973, vol. 7, # 9, p. 6 - 11
  • 36
  • [ 67-56-1 ]
  • [ 2862-47-7 ]
  • [ 102-52-3 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1968, p. 1129 - 1135
  • 37
  • [ 67-56-1 ]
  • [ 123331-77-1 ]
  • [ 7424-91-1 ]
  • [ 102-52-3 ]
Reference: [1] Monatshefte fuer Chemie, 1990, vol. 121, p. 203 - 207
[2] Monatshefte fuer Chemie, 1990, vol. 121, p. 203 - 207
  • 38
  • [ 108-05-4 ]
  • [ 7705-08-0 ]
  • [ 149-73-5 ]
  • [ 102-52-3 ]
Reference: [1] Patent: US2459076, 1948, ,
[2] Patent: US2459076, 1948, ,
  • 39
  • [ 107-25-5 ]
  • [ 109-63-7 ]
  • [ 149-73-5 ]
  • [ 123-59-1 ]
  • [ 102-52-3 ]
Reference: [1] Zhurnal Obshchei Khimii, 1957, vol. 27, p. 57,58,61;engl.Ausg.S.65,67,68
  • 40
  • [ 102-52-3 ]
  • [ 2065-75-0 ]
YieldReaction ConditionsOperation in experiment
39%
Stage #1: With hydrogenchloride In water at 20℃; for 0.166667 h;
Stage #2: With bromine In water at 20℃; for 1.16667 h;
A solution of 1,1,3,3-tetramethoxypropane (23) (10 g) and concentrated HCl (0.43 mL) in H2O (11 mL) was stirred at room temperature for 10 min. Br2 (3.1 mL) was added dropwise to the solution at room temperature for more than 50 min. The reaction mixture was stirred at room temperature for 20 min and concentrated in vacuo. The residual solid was washed with H2O to give 24 (3.6 g, 39percent) as a yellow solid. Mp 147–148 °C; 1H NMR (CDCl3) δ 4.73–4.80 (1H, m), 8.47 (2H, br s); FAB MS m/e (M−H) 149.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 1, p. 235 - 238
[2] Patent: US2005/85492, 2005, A1, . Location in patent: Page/Page column 25
[3] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 5, p. 1219 - 1233
[4] Organic and Biomolecular Chemistry, 2005, vol. 3, # 18, p. 3388 - 3398
[5] Patent: WO2004/67521, 2004, A1, . Location in patent: Page 68
  • 41
  • [ 102-52-3 ]
  • [ 107953-75-3 ]
  • [ 6342-70-7 ]
Reference: [1] Journal of Organic Chemistry, 2007, vol. 72, # 16, p. 6284 - 6286
  • 42
  • [ 102-52-3 ]
  • [ 3943-73-5 ]
Reference: [1] Journal of Organic Chemistry, 2007, vol. 72, # 16, p. 6284 - 6286
  • 43
  • [ 1021178-39-1 ]
  • [ 102-52-3 ]
  • [ 52159-67-8 ]
Reference: [1] Tetrahedron Letters, 2008, vol. 49, # 14, p. 2329 - 2332
[2] European Journal of Organic Chemistry, 2009, # 33, p. 5854 - 5867
  • 44
  • [ 102-52-3 ]
  • [ 57-13-6 ]
  • [ 38353-09-2 ]
Reference: [1] Organic Process Research and Development, 2007, vol. 11, # 2, p. 237 - 240
  • 45
  • [ 102-52-3 ]
  • [ 2582-30-1 ]
  • [ 4023-02-3 ]
Reference: [1] Journal of the American Chemical Society, 2010, vol. 132, # 32, p. 11223 - 11233
  • 46
  • [ 102-52-3 ]
  • [ 1937-19-5 ]
  • [ 4023-02-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2008, vol. 51, # 24, p. 8168 - 8172
  • 47
  • [ 102-52-3 ]
  • [ 31230-17-8 ]
  • [ 116834-96-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1997, vol. 40, # 17, p. 2706 - 2725
  • 48
  • [ 102-52-3 ]
  • [ 870-46-2 ]
  • [ 219580-32-2 ]
Reference: [1] Tetrahedron, 1998, vol. 54, # 49, p. 14679 - 14688
  • 49
  • [ 102-52-3 ]
  • [ 6825-71-4 ]
  • [ 1260169-02-5 ]
YieldReaction ConditionsOperation in experiment
58.1% at 100℃; for 14 h; To a solution of ethyl 3,5-diamino-lH-pyrazole-4-carboxylate (5.00 g, 29.38 mmol) in DMF (80 mL) were added 1 , 1 ,3,3-tetramethoxypropane (14.50 mL, 88.15 mmol) and AcOH (0.34 mL, 5.88 mmol). The reaction mixture was stirred at 100 °C for 14 h, and then concentrated in vacuo. The residue was partitioned between DCM (50 mL) and water (50 mL). The organic phase was separated and the aqueous phase was extracted with DCM (100 mL x 3). The combined organic phases were washed with brine (100 mL), dried over anhydrous Na2S04, filtered and concentrated in vacuo. The residue was purified by a silica gel column chromatography (a solution of NH3in MeOH (7 M)/DCM (v/v) =1/100) to give the title compound as a pale yellow solid (3.52 g, 58.1percent).MS (ESI, pos. ion) m/z: 207.1 [M+H]+; H NMR (400 MHz, CDC1 ): δ (ppm) 8.60 (dd, J= 4.40 Hz, 1.76 Hz, 1H), 8.46 (dd, J = 6.76 Hz, 1.76 Hz, 1H), 6.86 (dd, J = 6.72 Hz, 4.40 Hz, 1H), 4.50 (q, J = 7.08 Hz, 2H), 1.47 (t, J = 7.08 Hz, 3H).
58.1% With acetic acid In N,N-dimethyl-formamide at 100℃; for 14 h; To a solution of ethyl 3,5-diamino-1 -hydro-pyrazole-4-carboxylate (5.00 g, 29.38 mmol)In N, N-dimethylformamide ((80 mL)1,1,3,3-tetramethoxypropane (14.50 mL, 88.15 mmol)And acetic acid (0.34 mL, 5.88 mmol).After the reaction mixture was stirred at 100 ° C for 14 hours,Concentrate under reduced pressure. The resulting residue was dispersed in a mixed system of dichloromethane (50 mL) and water (50 mL), the organic phase was separated and the aqueous phase was extracted with dichloromethane (100 mL x 3). The combined organic phases were washed with saturated brine (100 mL x 3), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (NH3 in methanol (7M) / methylene chloride (v / v) = 1/100) to give the title compound as a pale yellow solid (3.52 g, 58.1percent).
35.3% With triethylamine In N,N-dimethyl-formamide at 100℃; for 14 h; ethyl 2-aminopyrazolo[l ,5-a]pyrimidine-3-carboxylateA mixture of ethyl 3,5-diamino-l H-pyrazole-4-carboxylate (1.0 g, 5.9 mmol), 1,1,3,3- tetramethoxypropane (2.9 mL, 18 mmol), triethylamine (2 mL, 10 mmol), and DMF (15 mL) was heated at 100 0C for 14 hrs, then a further 2 mL of 1,1,3,3-tetramethoxypropane was added. After adding the additional 1,1,3,3-tetramethoxypropane, a significant by-product was noted and heating was stopped immediately. The reaction was cooled to room temperature and the DMF was removed in vacuo. The residue was partitioned between DCM and water, then the organic layer was concentrated and the residue purified by silica chromatography, eluting with 95:5 DCM: 2M methanolic ammonia solution to afford 420 mg (35percent) of ethyl 2-aminopyrazolo[l,5- a]pyrimidine-3-carboxylate. 1H NMR (500 MHz, CDCl3) δ 8.57 (dd, J = 4.3, 1.6, IH), 8.43 (dd, J = 6.7, 1.6, IH), 6.84 (dd, J = 6.7, 4.4, IH), 5.52 (s, 2H), 4.48 (q, J= 7.1, 2H), 1.45 (t, J= 7.1, 3H).
Reference: [1] Patent: WO2015/73267, 2015, A1, . Location in patent: Paragraph 318
[2] Patent: CN104650092, 2017, B, . Location in patent: Paragraph 0463-0464; 0473-0474
[3] Patent: WO2011/3065, 2011, A2, . Location in patent: Page/Page column 110-111
[4] Patent: US2015/336962, 2015, A1, . Location in patent: Paragraph 0478
[5] Patent: WO2017/48702, 2017, A1, . Location in patent: Paragraph 001169; 001170; 001172
  • 50
  • [ 102-52-3 ]
  • [ 20357-20-4 ]
  • [ 1196155-68-6 ]
Reference: [1] Patent: WO2011/63233, 2011, A1, . Location in patent: Page/Page column 32
  • 51
  • [ 102-52-3 ]
  • [ 40887-80-7 ]
  • [ 294877-33-1 ]
Reference: [1] Magnetic Resonance in Chemistry, 2011, vol. 49, # 8, p. 537 - 542
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 102-52-3 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 16777-87-0

[ 16777-87-0 ]

3,3-Diethoxy-1-propanol

Similarity: 0.89

Chemical Structure| 36255-44-4

[ 36255-44-4 ]

3-Bromo-1,1-dimethoxypropane

Similarity: 0.71

Chemical Structure| 7424-91-1

[ 7424-91-1 ]

Methyl 3,3-dimethoxypropanoate

Similarity: 0.67

Chemical Structure| 24332-20-5

[ 24332-20-5 ]

1,1,2-Trimethoxyethane

Similarity: 0.67

Chemical Structure| 6342-56-9

[ 6342-56-9 ]

1,1-Dimethoxypropan-2-one

Similarity: 0.65

Ethers

Chemical Structure| 16777-87-0

[ 16777-87-0 ]

3,3-Diethoxy-1-propanol

Similarity: 0.89

Chemical Structure| 36255-44-4

[ 36255-44-4 ]

3-Bromo-1,1-dimethoxypropane

Similarity: 0.71

Chemical Structure| 64001-06-5

[ 64001-06-5 ]

4-((Tetrahydrofuran-2-yl)oxy)butan-1-ol

Similarity: 0.71

Chemical Structure| 696-59-3

[ 696-59-3 ]

2,5-Dimethoxytetrahydrofuran

Similarity: 0.68

Chemical Structure| 24332-20-5

[ 24332-20-5 ]

1,1,2-Trimethoxyethane

Similarity: 0.67